Jan Astermark
- Hematology top 0.1%
- Hemophilia Treatment and Research 144
- Blood Coagulation and Thrombosis Mechanisms 56
- Platelet Disorders and Treatments 46
- Chronic Myeloid Leukemia Treatments 21
- Hemostasis and retained surgical items 10
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 32
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Internal Medicine top 5%
- Molecular Biology top 10%
- Cancer-related gene regulation 28
- Co-authors
- Erik BerntorpJohannes OldenburgA. GringeriSharyne DonfieldRolf LjungKathelijn FischerDonna DiMichelePia Petrini
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Jan Astermark
156 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 104
- Hematology 5.0k
- Genetics 1.4k
- Internal Medicine 80
- Molecular Biology 1000
- Radiology, Nuclear Medicine and Imaging 241
Countries citing papers authored by Jan Astermark
This map shows the geographic impact of Jan Astermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Astermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Astermark more than expected).
Fields of papers citing papers by Jan Astermark
This network shows the impact of papers produced by Jan Astermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Astermark. The network helps show where Jan Astermark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Astermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 10 | |
| 8 | 2012 | 26 | |
| 9 | 2011 | 1 | |
| 10 | 2011 | 49 | |
| 11 | 2011 | 28 | |
| 12 | Mild haemophilia in Sweden | 2010 | 3 |
| 13 | 2010 | 28 | |
| 14 | 2008 | 3 | |
| 15 | 2008 | 262 | |
| 16 | 2006 | 82 | |
| 17 | 2006 | 43 | |
| 18 | 2003 | 98 | |
| 19 | Comparison of two prophylactic regimens for severe hemophilia: Intermediate dose versus high dose. | 2001 | 1 |
| 20 | Immune tolerance induction and the treatment of hemophilia. Malmö protocol update. | 2000 | 44 |
About Jan Astermark
Jan Astermark is a scholar working on Hematology, Genetics and Internal Medicine, having authored 163 papers that have together received 5.3k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (144 papers), Blood Coagulation and Thrombosis Mechanisms (56 papers), Platelet Disorders and Treatments (46 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (32 papers), Cancer-related gene regulation (28 papers), Chronic Myeloid Leukemia Treatments (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Hemostasis and retained surgical items (10 papers). The work is most often cited by research in Hematology (5.0k citations), Genetics (1.4k citations) and Internal Medicine (80 citations). Jan Astermark has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Erik Berntorp, Johannes Oldenburg, Erik Berntorp, A. Gringeri, Sharyne Donfield, Rolf Ljung, Kathelijn Fischer, Donna DiMichele, Pia Petrini and Sam Schulman. Their work appears in journals such as Haemophilia, Blood, Journal of Thrombosis and Haemostasis, Thrombosis Research and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.